Introduction: Individuals with persistently uncontrolled diabetes (Hemoglobin A1C ≥9) frequently face socioeconomic, behavioral, or other barriers to treatment plans despite optimal medical and education interventions. Despite demonstrated efficacy of one-on-one coaching, it is often not reimbursed by health insurance. Objective: At the UMass Memorial Diabetes Center of Excellence, we evaluated the financial sustainability and efficacy of a “Care Coach” program to provide additional services to these patients. Methods: Pharmacists from the UMass Specialty Pharmacy, trained in diabetes care, delivered high-frequency, individualized comprehensive coaching covering medication management, nutrition and lifestyle counseling, refill coordination, SDOH screening/referrals and mental health referrals. Results: Notable outcomes are A1C reduction averaging 2% (sustained at month 15) and over 50% lower rates of diabetes-related ER visits and hospitalizations (Table). The medical center investment of $2,666 per coach patient annually is offset by a combination of patients filling prescriptions through the Specialty Pharmacy and the 340B drug pricing program. Conclusion: With a third of Coach patients on Medicaid, the program showcases the potential of leveraging the 340B program to enhance care for the economically vulnerable, while reducing diabetes-related ER visits and hospitalizations. Disclosure S. Malkani: None. R.A. Haas: None. V. Shah: None. W. McElnea: None. L. Piz: None. C. Barry: None. H. Sharma: None. G. Pugliese: None. S. Lebel (Shnayderman): None.
No takes yet. Share an insight, caveat, or question.
Malkani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: